Suzhou Basecare Medical Corporation Limited (2170.HK)
HKD 2.98
(0.34%)
HKD 2.98
(0.34%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 281.91 Million CNY | 273.2% |
| 2022 | 75.54 Million CNY | 55.54% |
| 2021 | 48.56 Million CNY | 54.33% |
| 2020 | 31.46 Million CNY | -3.49% |
| 2019 | 32.6 Million CNY | 31.69% |
| 2018 | 24.76 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 328.32 Million CNY | 2.97% |
| 2024 Q1 | 328.32 Million CNY | 16.46% |
| 2023 Q4 | 281.91 Million CNY | 1.69% |
| 2023 FY | 281.91 Million CNY | 273.2% |
| 2023 Q3 | 277.23 Million CNY | 22.11% |
| 2023 Q2 | 227.03 Million CNY | 1.65% |
| 2023 Q1 | 223.35 Million CNY | 195.68% |
| 2022 Q3 | 73.39 Million CNY | 42.5% |
| 2022 Q2 | 51.5 Million CNY | 7.58% |
| 2022 Q1 | 47.87 Million CNY | -1.42% |
| 2022 FY | 75.54 Million CNY | 55.54% |
| 2022 Q4 | 75.54 Million CNY | 2.92% |
| 2021 FY | 48.56 Million CNY | 54.33% |
| 2021 Q1 | 22.69 Million CNY | -27.87% |
| 2021 Q4 | 48.56 Million CNY | 6.7% |
| 2021 Q3 | 45.51 Million CNY | 80.2% |
| 2021 Q2 | 25.25 Million CNY | 11.28% |
| 2020 Q3 | 31.9 Million CNY | 2.48% |
| 2020 Q2 | 31.12 Million CNY | 0.0% |
| 2020 Q1 | 31.12 Million CNY | -4.54% |
| 2020 Q4 | 31.46 Million CNY | -1.35% |
| 2020 FY | 31.46 Million CNY | -3.49% |
| 2019 Q4 | 32.6 Million CNY | 0.0% |
| 2019 FY | 32.6 Million CNY | 31.69% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 24.76 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 37.38 Million HKD | -654.091% |